Society of Nuclear Medicine/GE Healthcare offer new visiting physician/scientist program grant

October 04, 2005

RESTON, Va.--Three $10,000 competitive grants from the Society of Nuclear Medicine--funded with the generous support of GE Healthcare--each provide for a nuclear medicine/molecular imaging physician or scientist from North America to spend one to two weeks to lecture, consult and train at one or more institutions/organizations in China or India.

"This innovative grant program--made possible with an exceptional donation from GE Healthcare--provides an unprecedented opportunity that benefits the entire nuclear medicine and molecular imaging community as we work together to advance patient care around the globe," said SNM President Peter S. Conti, M.D., Ph.D. "This international collaboration can lead to a better understanding of human disease and the development of life-saving treatments," he added. Kevin Brooks, global marketing director at GE Healthcare, stated, "Nuclear medicine continues to be an important modality globally, and GE Healthcare is delighted to have this opportunity to participate in SNM's international visiting physician/scientist program."

The SNM/GE Healthcare Visiting Physician/Scientist Program Grant for China and India will cover travel and per diem costs. During a one- or two-week period, a visiting physician/scientist will spend time lecturing, training and consulting on nuclear medicine/molecular imaging. "With this grant program, SNM continues its strong commitment in the international arena by seeking to enhance interactions to promote educational activities," noted Mathew L. Thakur, Ph.D., SNM immediate past president and chair of the society's Grants and Awards Committee. "I want to thank GE Healthcare for its generosity in supporting SNM's international initiative and this partnership," he added.

Eligible applicants include clinical centers, hospitals, academic institutions or consortia of institutions that have active nuclear medicine programs in China and India. International societies of nuclear medicine based in these countries may also apply. Program visits must take place during the 2006 calendar year. The deadline for receipt of applications is Nov. 4, 2005; award notifications will be made by Jan. 10, 2006. Members of SNM's Grants and Awards Committee will evaluate applications based on the need and the potential for educational enrichment.
Online applications are available at For additional information, contact Kathy Bates, SNM director of development, via e-mail at or by phone at (703) 708-9000, ext. 1028.

About the Society of Nuclear Medicine
The Society of Nuclear Medicine is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of nuclear medicine and molecular imaging. Annually, more than 20 million men, women and children undergo noninvasive nuclear medicine/molecular imaging procedures. These safe, effective and painless procedures include positron emission tomography (PET) scans to diagnose and monitor treatment in cancer, cardiac stress tests to analyze heart function, bone scans for orthopedic injuries and lung scans for blood clots. SNM is based in Reston, Va.; additional information can be found online at

About GE Healthcare
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring and life support systems, disease research, drug discovery and biopharmaceutical manufacturing technologies is helping physicians detect disease earlier and to tailor personalized treatments for patients. GE Healthcare offers a broad range of products and services that are improving productivity in healthcare and enhancing patient care by enabling healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

Society of Nuclear Medicine

Related Nuclear Medicine Articles from Brightsurf:

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Story tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine
ORNL Story Tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine.

Global nuclear medicine community shares COVID-19 strategies and experiences
In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

Influence of the Journal of Nuclear Medicine jumps 25%
The Journal of Nuclear Medicine again ranks among the top 5 medical imaging journals in the world.

Nuclear medicine PSMA-targeted study offers new options for cancer theranostics worldwide
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer imaging and radioligand therapy (theranostics).

Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome.

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging
A nuclear medicine imaging procedure can pinpoint prostate cancer with superior accuracy, allowing more precisely targeted treatment, according to new research featured in the November 2018 issue of The Journal of Nuclear Medicine.

New nuclear medicine tracer will help study the aging brain
A new PET imaging radiotracer could help researchers understand neurodegenerative disease and the aging brain.

New nuclear medicine imaging method shows strong potential for cancer imaging
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

New nuclear medicine technique could help tackle brain disease
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

Read More: Nuclear Medicine News and Nuclear Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to